Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001013762-23-001300

Chief Financial Officer acquired 62,972 shares (conversion)

  • Chief Financial Officer returned 62,972 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bodenstedt Matthias Chief Financial Officer 2023-10-01 Conversion +62,972 620,903 D
Bodenstedt Matthias Chief Financial Officer 2023-10-01 Returned to the company −62,972 294,473 D
Derivatives
Bodenstedt Matthias Chief Financial Officer 2023-10-01 Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −1,872 8,754 D
Loading xslF345X05/ownership.xml…